BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder Treatment

PARK CITY, Utah, and HERZLIYA, Israel /PRNewswire/ — BlueWind Medical, Ltd., developer of the innovative RENOVA iStim implantable tibial neuromodulation device under investigation for the treatment of urgency incontinence alone or in combination with urinary urgency and/or urinary frequency, today announced the closing of a $64 million Series B funding round. This round of financing was led by ConvaTec, a global medical products and technologies company focused on therapies for the management of chronic conditions including continence care. Read more…